JBC INTERFERin siRNA transfection reagent

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M406331200 on October 25, 2004 Originally published In Press as doi:10.1074/jbc.M406331200 on October 20, 2004

J. Biol. Chem., Vol. 279, Issue 52, 54826-54832, December 24, 2004
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
279/52/54826    most recent
M406331200v2
M406331200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ikari, A.
Right arrow Articles by Takagi, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ikari, A.
Right arrow Articles by Takagi, K.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Association of Paracellin-1 with ZO-1 Augments the Reabsorption of Divalent Cations in Renal Epithelial Cells*

Akira Ikari{ddagger}§, Naho Hirai{ddagger}, Morihiko Shiroma{ddagger}, Hitoshi Harada{ddagger}, Hideki Sakai¶, Hisayoshi Hayashi||, Yuichi Suzuki||, Masakuni Degawa**, and Kuniaki Takagi{ddagger}

From the {ddagger}Department of Environmental Biochemistry and Toxicology, School of Pharmaceutical Sciences, **Department of Molecular Toxicology and the 21st Century COE program, School of Pharmaceutical Sciences, and ||Laboratory of Physiology, School of Food and Nutritional Sciences, University of Shizuoka, 52-1 Yada, Shizuoka 422-8526, Japan and the Department of Pharmaceutical Physiology, Faculty of Pharmaceutical Sciences, Toyama Medical and Pharmaceutical University, 2630 Sugitani, Toyama 930-0194, Japan

Received for publication, June 7, 2004 , and in revised form, October 15, 2004.


    ABSTRACT
 TOP
 ABSTRACT
 INTRODUCTION
 EXPERIMENTAL PROCEDURES
 RESULTS
 DISCUSSION
 REFERENCES
 
Paracellin-1 (PCLN-1) belongs to the claudin family of tight junction proteins and possibly plays a critical role in the reabsorption of magnesium and calcium. So far, the physiological properties of PCLN-1 have not been clarified. In the present study, we investigated whether PCLN-1 is associated with ZO-1. We also investigated whether 45Ca2+ transport across the paracellular barrier is affected by this association. In vitro binding analysis using glutathione S-transferase fusion protein showed that the C-terminal TRV sequence, especially Thr and Val residues, of PCLN-1 interacts with ZO-1. Next, PCLN-1 was stably expressed in Madin-Darby canine kidney cells using a FLAG tagging vector. ZO-1 was co-immunoprecipitated with the wild-type PCLN-1 and the alanine substitution (TAV) mutant. However, mutants of the deletion ({Delta}TRV) and the alanine substitution (ARV and TRA) inhibited the association of PCLN-1 with ZO-1. Confocal immunofluorescence demonstrated that the wild-type PCLN-1 and the TAV mutant localized in the tight junction along with ZO-1, but the {Delta}TRV, ARV, and TRA mutants were widely distributed in the lateral membrane including the tight junction area. Interestingly, monolayers of cells expressing the wild-type PCLN-1 and the TAV mutant showed higher activities of 45Ca2+ transport from apical to basal compartments, compared with those expressing the {Delta}TRV, ARV, and TRA mutants and the mock cells. 45Ca2+ transport was inhibited by increased magnesium concentration suggesting that magnesium and calcium were competitively transported by PCLN-1. It was noted that a positive electrical potential gradient enhanced 45Ca2+ transport from apical to basal compartments without affecting the opposite direction of transport. Thus, PCLN-1 localizes to the tight junction followed by association with ZO-1, and the PCLN-1·ZO-1 complex may play an essential role in the reabsorption of divalent cations in renal epithelial cells.


    INTRODUCTION
 TOP
 ABSTRACT
 INTRODUCTION
 EXPERIMENTAL PROCEDURES
 RESULTS
 DISCUSSION
 REFERENCES
 
Magnesium is an important cofactor for various enzymes. The bodies magnesium balance is regulated by the kidney, which adapts magnesium excretion based on net magnesium absorption from intestine. Renal magnesium filtrated in the glomeruli is predominantly reabsorbed through the paracellular pathway in the thick ascending limb (TAL)1 of Henle (1). However, the molecular nature of magnesium reabsorption in TAL was unknown for many years.

Tight junction (TJ) forms apical junctional complexes in epithelial and endothelial cells and plays a central role in the maintenance of barrier and cell polarity (2, 3). These functions are facilitated by occludin and claudin family. So far, at least 22 mammalian isoforms of claudin have been identified, and their spatial distribution patterns in some epithelial tissues have been clarified. Paracellin-1 (PCLN-1), cloned by Simon et al. (4), is a most cogent protein that undertakes magnesium reabsorption, because (1) homozygous mutations in the PCLN-1 gene are associated with a rare familial hypomagnesemia with hypercalciuria and nephrocalcinosis (FHHNC), and (2) PCLN-1 is exclusively expressed in the TJ of TAL. PCLN-1 belongs to the claudin family (named claudin-16), which composes a TJ strand and is the most distantly related member of this family. Amino acid homology between PCLN-1 and individual claudin is very low (10–18%), but these proteins have a consensus PSD95/DglA/ZO-1-like domain (PDZ)-binding motif at the C terminus (5).

Protein-protein interactions mediated by the PDZ-binding motif occur through the PDZ domains in multiple members of the membrane-associated guanylate kinases (6). Membrane-associated guanylate kinases contain several PDZ domains, an SH3 domain, and a C-terminal guanylate kinase homology region that may act as a protein-binding domain (7, 8). Among them, ZO-1 and ZO-2 are localized at the TJ area and they may anchor transmembrane proteins, such as occludin and claudin family. Thus, the interactions between transmembrane proteins and cytoplasmic molecules may modulate paracellular permeability.

The direct binding of ZO-1 with the C terminus (YV sequence) of claudin-1–8 has been revealed by an in vitro binding assay using glutathione S-transferase (GST) fusion protein and in vivo immunofluorescence analysis (9). However, the C terminus (TRV sequence) of PCLN-1 is different from that of other proteins in the claudin family, and the function of PCLN-1 has not been clarified yet. In the present study, we found the association between ZO-1 and the C-terminal TRV sequence of PCLN-1. Furthermore, the function of PCLN-1 was established by measurements of transepithelial electrical resistance (TER) and 45Ca2+ transport.


    EXPERIMENTAL PROCEDURES
 TOP
 ABSTRACT
 INTRODUCTION
 EXPERIMENTAL PROCEDURES
 RESULTS
 DISCUSSION
 REFERENCES
 
Materials—Rabbit polyclonal ZO-1 antibody was obtained from Zymed Laboratories Inc. Mouse monoclonal FLAG M2 antibody and G418 sulfate were from Sigma. Fluorescein isothiocyanate-labeled anti-rabbit IgG was from Kirkegaard & Perry Laboratories (Guildford, UK). Goat polyclonal GST antibody, protein G-Sepharose beads, and 45CaCl2 was from Amersham Biosciences. Goat polyclonal occludin antibody and goat polyclonal PCLN-1 antibody were from Santa Cruz Biotechnology (Santa Cruz, CA). Lipofectamine 2000 was from Invitrogen. All other reagents were of the highest grade of purity available.

Plasmid cDNA Constructs—Rat PCLN-1 cDNA containing the whole open reading frame was amplified by the reverse transcriptase-PCR from rat kidney mRNA using the set of primers, 5'-CGATATCCATGAAGGATCTTCTTC-3' (sense) and 5'-CCGGTCGACTTACACTCTCGTGTC-3' (antisense). The PCLN-1 cDNA was subcloned into the mammalian expression vector, pCMV-Tag2A (BD Biosciences Clontech), containing the FLAG epitope. Additional FLAG-PCLN-1 cDNA encoding PCLN-1 with point substitutions in the C-terminal PDZ-binding motif (substitutions are underlined, FLAG-PCLN-1-ARV, FLAG-PCLN-1-TAV, FLAG-PCLN-1-TRA) and with the deletion mutant (FLAG-PCL-N-1-{Delta}TRV) were constructed by PCR using the above sense and the antisense primers (ARV, 5'-CCGGTCGACTTACACTCTCGCGTC-3'; TAV, 5'-CCGGTCGACTTACACTGCCGTGTC-3'; TRA, 5'-CCGGTCGACTTACGCTCTCGTGTC-3'; {Delta}TRV, 5'-CGTCGACTTAGTCTACAGCGTAC-3'). Fusion proteins of the C terminus of PCLN-1 with GST were constructed by subcloning PCR amplified DNA fragments into pGEX-4T-1 (Amersham Biosciences) to yield GST-PCLN-1-{Delta}TRV, GST-PCLN-1-TRA, GST-PCLN-1-TAV, and GST-PCLN-1-ARV, respectively. All wild-type and mutant PCLN-1 constructs were verified by DNA sequencing.

In Vitro Binding Assay—The plasmids of GST-PCLN-1-{Delta}TRV, GST-PCLN-1-ARV, GST-PCLN-1-TAV, and GST-PCLN-1-TRA were transformed in Escherichia coli BL21. GST fusion proteins were purified with glutathione-Sepharose 4B beads (Amersham Biosciences). The beads were incubated with lysate of Madin-Darby canine kidney (MDCK) cells in a buffer composed of 10 mM Tris-HCl (pH 7.5), 150 mM NaCl, 0.1% Nonidet P-40, 2 mM EDTA, 1 mM phenylmethylsulfonyl fluoride, and protease inhibitor mixture (Sigma) for 4 h at 4 °C. Then, bound proteins were eluted with a sample buffer and applied to the SDS-polyacrylamide gel. Proteins were blotted onto a polyvinylidene difluoride membrane and incubated for 1 h with each primary antibody followed by peroxidase-conjugated secondary antibody. The blots were visualized as described in the Western blotting section.

Cell Culture and Transfection—MDCK cells were obtained from the European Collection of Cell Cultures (#84121903, Wiltshire, UK). Cells were grown in Dulbecco's modified Eagle's medium (Sigma) supplemented with 5% Fetal Clone III (HyClone Laboratories, Logan, UT), 0.07 mg/ml penicillin-G potassium, and 0.14 mg/ml streptomycin sulfate in a 5% CO2 atmosphere at 37 °C. MDCK cells were transfected with expression plasmids using Lipofectamine 2000 as indicated in the manufacture's protocol. Stable transfectants were selected with 0.5 mg/ml G418 sulfate and maintained in the continuous presence of the selecting drug. Cell lines expressing FLAG-tagged protein were screened by Western blotting.

Preparation of Membrane Fraction and Immunoprecipitation— Whole membrane fraction was prepared from MDCK cells on day 7 in culture as described previously (10). The samples were solubilized in a lysis buffer containing 1% Triton X-100, 150 mM NaCl, 0.5 mM EDTA, and 50 mM Tris-HCl (pH 8.0) and incubated with protein G-Sepharose beads and an antibody specific for GST at 4 °C for 1 h with gentle rocking. After centrifugation at 6000 x g for 1 min, the pellet was washed four times with the lysis buffer. The pellet was solubilized in the sample buffer for SDS-polyacrylamide gel electrophoresis. Protein concentration was measured using the protein assay kit (Bio-Rad Laboratories) with bovine serum albumin as the standard.

SDS-Polyacrylamide Gel Electrophoresis and Western Blotting— SDS-polyacrylamide gel electrophoresis was carried out as described previously (11). In brief, whole membrane fractions (30 µg) or immunoprecipitants were applied to the SDS-polyacrylamide gel. Proteins were blotted onto a polyvinylidene difluoride membrane and incubated for 1 h with each primary antibody followed by a peroxidase-conjugated secondary antibody. Finally, the blots were stained with the ECL Western blotting kit from Amersham Biosciences.

Immunofluorescence Microscopy—The cells grown on cover glass for 7 days were washed twice with phosphate-buffered saline supplemented with 0.5 mM CaCl2 and 0.5 mM MgCl2 prior to fixation with 3% paraformaldehyde for 7 min at room temperature. After permeabilization with 0.3% Triton X-100 for 15 min and blocking with 5% skim milk in phosphate-buffered saline for 30 min, the cells were incubated with an anti-ZO-1 antibody and an anti-FLAG antibody (final dilution 1/100) for 60 min at room temperature. They were then washed three times with phosphate-buffered saline, followed by incubation with Texas Redlabeled anti-goat IgG and fluorescein isothiocyanate-labeled anti-rabbit IgG in a blocking solution (dilution 1/100) for 60 min. Immunolabeled cells were visualized on an LSM 510 confocal microscope (Carl Zeiss, Germany) set with the appropriate filter for Texas Red (543 nm excitation, 585–615 nm emission filter) and fluorescein isothiocyanate (488 nm excitation, 530 nm emission filter). Images were further processed using Adobe Photoshop (Adobe System, Inc).

Measurement of TER and Transepithelial Transport Assay—MDCK cells were plated at confluent densities on transwells with polyester membrane inserts (Corning Life Sciences, Acton, MA). TER was measured three times for each well at indicated times using a Millicell-ERS epithelial volt-ohmmeter (Millipore, Bedford, MA), and averaged values were collected. TER values (ohm x cm2) were normalized by the area of the monolayer and calculated by subtracting the blank values from the filter and the bathing medium. Transepithelial transport of 45Ca2+ across confluent MDCK cells was evaluated as described previously (12). Briefly, at time 0, a transport buffer containing 0.5 µCi/ml 45Ca2+ was poured into the filter well or the outside compartment. The transport buffer contained 140 mM NaCl, 5.8 mM KCl, 0.34 mM Na2HPO4, 0.44 mM KH2PO4, 1 mM CaCl2, 1 mM MgCl2, 25 mM glucose, and 20 mM Hepes, pH 7.4. As indicated, the concentration of MgCl2 was changed from 0 to 10 mM. The reverse compartment was filled with the transport buffer without 45Ca2+, CaCl2, and MgCl2. The filter plates were shaken horizontally at a frequency of 50 oscillations/min at room temperature. To evaluate the permeability of the monolayers, the opposite compartment media were collected after indicated periods. The amount of 45Ca2+ was determined with a liquid scintillation counter.

Electrophysiological Studies with the Ussing Chamber—Cells were plated at confluent densities on transwells with polyester membrane inserts. The filter rings were detached and mounted in Ussing chambers that were incubated in the transport buffer at 37 °C. The fluid volume on each side of the filter was 4 ml. 45Ca2+ transport was measured under short-circuit conditions with an amplifier (CEZ9100, Nihon Kohden, Tokyo, Japan). The transepithelial voltage was clamped at -10, 0, or +10 mV. A time 0, the transport buffer containing 0.5 µCi/ml 45Ca2+ was added to one side. After 30 min, 1 ml of the transport solution was collected from the trans compartment for liquid scintillation counting.

Statistics—Results are presented as means ± S.E. Differences between groups were analyzed by one-way analysis of variance, and correction for multiple comparison was made using Tukey's multiple comparison test. Significant differences were assumed at p < 0.05.


    RESULTS
 TOP
 ABSTRACT
 INTRODUCTION
 EXPERIMENTAL PROCEDURES
 RESULTS
 DISCUSSION
 REFERENCES
 
Association of the C-terminal Domain of PCLN-1 with ZO-1— PCLN-1 has a typical PDZ-binding motif, TRV, at the C terminus. Here we examined whether the C terminus of PCLN-1 can associate with ZO-1. The cytoplasmic C-terminal domain of PCLN-1 was expressed as a fusion protein with GST and immobilized on glutathione-Sepharose beads (Fig. 1A). ZO-1 associated with the wild-type PCLN-1 but not with GST alone (Fig. 1B). The alanine substitution mutant for arginine (TAV) of the PDZ-binding motif bound to ZO-1, similarly to the wild-type, but the deletion mutant ({Delta}TRV) and the alanine substitution mutants for threonine (ARV) or valine (TRA) did not. Our point substitution studies indicated that C-terminal threonine and valine are critical residues in the association of PCLN-1 with ZO-1.



View larger version (25K):
[in this window]
[in a new window]
 
FIG. 1.
Effects of the PDZ-binding motif of PCLN-1 on the interaction with ZO-1. A, schematic description of GST-fused PCLN-1 proteins. B, GST and GST-fused proteins bound to glutathione-Sepharose beads were incubated with the lysate proteins (500 µg) from MDCK cells. The proteins on the beads were eluted with the sample buffer and immunoblotted with anti-GST antibody or anti-ZO-1 antibody.

 
Co-immunoprecipitation of PCLN-1 with ZO-1—It was reported that myc-tagged or hemagglutinin-tagged claudin family proteins were concentrated with occludin at TJ when they were introduced into MDCK cells (13, 14). We examined whether the C-terminal cytoplasmic domain of PCLN-1 affects the localization of PCLN-1 at TJ. The wild-type and the mutants of FLAG-tagged PCLN-1 were stably expressed in MDCK cells. These cell lines equally expressed FLAG-tagged PCLN-1 proteins (Fig. 2). Mock MDCK cells showed no expression of endogenous PCLN-1. The introductions did not affect endogenous occludin and ZO-1 expressions. ZO-1 was co-immunoprecipitated with the wild-type PCLN-1 indicating that exogenous PCLN-1 could interact with endogenous ZO-1. ZO-1 was also co-immunoprecipitated with the TAV mutant. By contrast, ZO-1 could not be co-immunoprecipitated with the {Delta}TRV, ARV, and TRA mutants. These results are similar to those of the GST pull-down assay (Fig. 1) indicating that the association of PCLN-1 with ZO-1 requires the C-terminal threonine and valine residues of PCLN-1.



View larger version (45K):
[in this window]
[in a new window]
 
FIG. 2.
Co-immunoprecipitation of ZO-1 with wild-type and mutant PCLN-1 in stably transfected MDCK cells. MDCK cells were stably transfected by mock, wild-type PCLN-1, and mutants of {Delta}TRV, ARV, TAV, and TRA. Cell lysates were prepared from the cells in confluent conditions. Expression of PCLN-1 in all clones was confirmed by Western blotting analysis using anti-FLAG antibody or anti-PCLN-1 antibody. Expressions of endogenous occludin and ZO-1 were not affected by transfection of PCLN-1. ZO-1 was co-immunoprecipitated with the wild-type and TAV mutant PCLN-1 (IP: FLAG). IP, immunoprecipitate.

 
Association of PCLN-1 with ZO-1 Is Essential for the Localization of PCLN-1 at TJ—The deletion mutants of the cytosolic C-terminal domain of occludin and claudin-1 inhibited the association between occludin and ZO-1 and the localization of these molecules at TJ (13, 15). However, these mutants were expressed in the lateral membranes without binding to ZO-1. We examined the localization of FLAG-tagged PCLN-1 in MDCK cells. Expression levels of the wild-type PCLN-1 and the mutants were same as judged from the levels of FLAG expression (Fig. 3, green fluorescence). These results are similar to those of the Western blotting (Fig. 2). The xz-scan images showed that merged yellow spots (Fig. 3) appeared near the most apical regions in the wild-type and TAV mutant, indicating these proteins were co-localized with ZO-1 at the TJ. In contrast, green fluorescence of merged images in the middle position was detected in mutants of {Delta}TRV, ARV, and TRA. Furthermore, these mutants were widely distributed in the lateral membrane including the TJ area, as shown by xz-scan imaging, indicating that PCLN-1 is distributed in the plasma membrane without binding to ZO-1. These results suggest that the association of PCLN-1 with ZO-1 is necessary for the concentration of PCLN-1 at TJ.



View larger version (54K):
[in this window]
[in a new window]
 
FIG. 3.
Localization of PCLN-1 in MDCK cells. Immunofluorescence staining of PCLN-1 with anti-FLAG antibody was performed using confocal microscopy. The cells were double-stained with FLAG (green) and ZO-1 (red). The xy-sections of merged images represent the area of the tight junction (top) and the lateral membrane (middle). Right panels (xz) show the vertical sections indicated by the triangle at the merged images. Wild-type and TAV mutant PCLN-1 show staining at the apical side of the intercellular junction, where it co-localized with ZO-1 (yellow). The {Delta}TRV, ARV, and TRA mutants distributed widely in the plasma membrane and intracellular compartments (middle). The scale bar represents 10 µm.

 
Expression of PCLN-1 Increases TER—The mock and PCLN-1-transfected cells were cultured in transwell inserts. In the mock cells, the TER value rose during 3 days and reached a maximum (139.2 ± 4.8 ohm x cm2). TER then decreased to a value of 70.1 ± 2.2 ohm x cm2 after 7 days. This value remained constant for up to 2 weeks after plating. The values and the pattern of time-dependent change of TER were similar to those in previous reports (1618). The peak and steady state values of TER were compared among mock, wild-type, and mutant cells (Fig. 4, A and B). In the wild-type and TAV mutants, both peak and steady states values of TER were higher than those in the mock, {Delta}TRV, ARV, and TRA mutants. These results indicated that the barrier function was enhanced by the expression of wild-type and TAV mutant at TJ.



View larger version (18K):
[in this window]
[in a new window]
 
FIG. 4.
Increase of TER by the PCLN-1 expression. Mock, wild-type, and mutants of PCLN-1 expressing cells were cultured on transwell inserts. A, TER value rose during 3 days after plating and reached a maximum. B, TER then decreased slowly and remained in a steady state after 7 days. n = 6–8. * and **, significantly different from mock cells (p < 0.05 and p < 0.01, respectively).

 
Expression of PCLN-1 Increases Transepithelial 45Ca2+ Transport—To functionally characterize the wild-type and the mutants of PCLN-1 expressed in MDCK cells, we measured transepithelial 45Ca2+ transport. Because the MDCK cell monolayer at day 7 in culture showed steady state TER and low permeability of fluorescein isothiocyanate-dextran 20,000 (data not shown), we used these cells for the assay. 45Ca2+ transport from apical to basal compartments increased time dependently in mock cells (Fig. 5A). In the cells expressing wild-type PCLN-1, 45Ca2+ transport from apical to basal compartments was higher than that of mock cells. On the contrary, the values of 45Ca2+ transport from basal to apical compartments were the same between the mock cells and the cells expressing the wild-type PCLN-1 (Fig. 5B). At 60-min time points, the net 45Ca2+ transport values from apical to basal compartments in the wild-type and TAV mutant were significantly higher than those in the mock, {Delta}TRV, ARV, and TRA mutants (Fig. 5C). These results indicate that the association of PCLN-1 with ZO-1 is necessary for the functional expression of PCLN-1 protein in MDCK cells. Next, we examined the effect of extracellular magnesium concentration on 45Ca2+ transport. The addition of MgCl2 in the apical compartment led to a decrease in 45Ca2+ transport in cells expressing the wild-type PCLN-1 (Fig. 6A). However, the change in 45Ca2+ transport by the addition of MgCl2 was not observed in the mock cells. It was noted that 45Ca2+ transport from basal to apical compartments was also unaffected by MgCl2. These results indicated that the PCLN-1·ZO-1 complex competitively transports calcium and magnesium from apical to basal compartments.



View larger version (13K):
[in this window]
[in a new window]
 
FIG. 5.
Increase of transepithelial 45Ca2+ transport by PCLN-1 expression. A and B, mock (•) and wild-type PCLN-1 ({circ})-expressing cells were cultured on transwell inserts for 7 days. 45Ca2+ was added to apical (A) or basal (B) compartments, and then the contralateral compartment was collected at indicated periods. The calcium concentration of the transport buffer was 1 mM in the 45Ca2+-added side and nominally 0 mM in the opposite side, respectively. C, mock, wild-type, and mutants of PCLN-1 expressing cells were cultured for 7 days. 45Ca2+ transport was estimated 60 min after adding 45Ca2+. The value of 45Ca2+ transport from basal to apical compartments was subtracted from all values from apical to basal compartments. n = 4–5. **, significantly different from mock cells (p < 0.01).

 



View larger version (19K):
[in this window]
[in a new window]
 
FIG. 6.
Inhibition of transepithelial 45Ca2+ transport by magnesium. A, mock (open columns) and wild-type PCLN-1 (hatched columns)-expressing cells were cultured on transwell inserts for 7 days. 45Ca2+ was added to the apical compartment, and then the basal compartment was collected after 60 min. The concentration of MgCl2 was changed from 0 to 10 mM in the transport solution of the apical compartment. CaCl2 concentration was invariable at 1 mM. B, 45Ca2+ was added to the basal compartment, and then the apical compartment was collected after 60 min. The concentration of MgCl2 was changed from 0 to 10 mM in the transport solution of the basal compartment. n = 4. **, significantly different from mock cells (p < 0.01). NS, not significantly different (p > 0.05).

 
Effect of the Electric Potential Gradient on Transepithelial 45Ca2+ Transport—As shown in Fig. 5, PCLN-1 enhanced unidirectional 45Ca2+ transport from apical to basal compartments. Next, we examined the effects of electrical potential gradients on 45Ca2+ transport. The cell layer on the membrane filter was mounted in Ussing chambers and bathed with the transport solution. The values of transepithelial potential in the mock cells and the cells expressing the wild-type PCLN-1 were 0.45 ± 0.03 mV (n = 18) and 0.43 ± 0.03 mV (n = 18) with the apical surface negative, respectively. When the transepithelial potential was clamped at 0 mV, the 45Ca2+ transport from apical to basal compartments in the PCLN-1 expressing cells was larger than that in the mock cells (Fig. 7A). The difference in 45Ca2+ transport became larger at +10 mV. It was noted that 45Ca2+ transport from basal to apical compartments of the mock cells was similar to that of the cells expressing the wild-type PCLN-1 (Fig. 7B). These results suggest that divalent cations are reabsorbed by PCLN-1 according to the electrical potential gradient.



View larger version (13K):
[in this window]
[in a new window]
 
FIG. 7.
Increase of transepithelial 45Ca2+ transport by positive electric potential gradient. Mock (•) and wild-type PCLN-1 ({circ})-expressing cells were cultured on transwell inserts for 7 days. The filter rings were detached and mounted in the Ussing chambers. The transepithelial voltage was clamped at -10, 0, or +10 mV. The transport solution containing 45Ca2+ was added to apical (A) or basal (B) compartments, and then the contralateral compartment was collected after 30 min. n = 5–6. * and **, significantly different from mock cells (p < 0.05 and p < 0.01, respectively).

 

    DISCUSSION
 TOP
 ABSTRACT
 INTRODUCTION
 EXPERIMENTAL PROCEDURES
 RESULTS
 DISCUSSION
 REFERENCES
 
The paracellular pathway of renal tubules has paradoxical roles, the reabsorption of solutes and acting as a transepithelial barrier. Unlike transmembrane ion channels, the paracellular pathway shows selectivity for net charges rather than for specific ions. These functions are facilitated by occludin and claudin family. PCLN-1 is a cogent protein that undertakes calcium and magnesium reabsorption in the TAL of Henle. Various mutations of PCLN-1 within the extracellular loops or the transmembrane domains have been identified in patients with FHHNC (4, 19, 20). Recently, Muller et al. (21) reported a novel mutation at the C-terminal Thr residue of the PDZ-binding motif that inhibits the association of PCLN-1 with ZO-1 in patients with idiopathic hypercalciuria. So far, biochemical and cell biological characterizations of the PDZ-binding motif of PCLN-1 have not been examined. In the present study, we revealed that the Thr and Val residues, but not the Arg residue, of the PDZ-binding motif are essential for the association of PCLN-1 with ZO-1 using the GST pull-down assay and immunoprecipitation analysis. If PCLN-1 is free from ZO-1, most of the PCLN-1 is not localized in TJ but in the lateral membrane of MDCK cells. However, only a small quantity of mutants that are free from ZO-1 may localize at TJ, because the merged yellow fluorescence of PCLN-1 and ZO-1 was indistinctly detected near the apical side (Fig. 3). Similarly, myc-tagged claudin-1, which may interfere with its association with ZO-1, has been reported to be distributed in the lateral membrane of MDCK cells (18). Our results suggest that ZO-1 plays a critical role in the localization of PCLN-1 at TJ.

The properties of claudin-1, -2, -4, -8, and -15 have been well characterized in the over-expression model of MDCK cells. Claudin-1 increases TER, and the flux of small solutes such as mannitol and fluorescein isothiocyanate-dextran (18). Claudin-4 decreases paracellular conductance resulting from a selective decrease in Na+ permeability (22). Claudin-8 increases TER via the reduction of paracellular permeability to monovalent inorganic and organic cations and divalent cations (16). In contrast, claudin-2 increases paracellular cation conductance without changing mannitol flux (23). Our present results showed for the first time that the PCLN-1·ZO-1 complex increases TER and the paracellular permeability of divalent cations. Thus, the effects of claudins on TER and paracellular ion selectivity are type-specific. Why did PCLN-1 expression cause increased divalent cation transport despite an increase in TER in MDCK cells? We hypothesize that PCLN-1 expression increases protein density in restricted TJ areas, because it did not change the expression level of endogenous occludin, and PCLN-1 constructs a pore that is selectively permeable to divalent cations. In the mock cells and cells expressing wild-type PCLN-1, the removal of Na+ or Cl- from the bathing media increased TER, but Mg2+ removal did not change TER (data not shown). Similarly, paradoxical increases in TER and the paracellular flux of mannitol and dextran were observed in MDCK cells expressing occludin (24) and claudin-1 (18).

PCLN-1 did not affect endogenous ZO-1 levels, consistent with previous reports on claudin-1 (18) and claudin-4 expression (22). The deletion of the PDZ-binding motif (YV) at the C terminus of claudin-1–8 was enough to inhibit the association of claudins with ZO-1, but the mutants could be still distributed at the TJ (9). On the contrary, PCLN-1 mutants with the substitution of Thr for Arg at the C terminus led to lysosomal mistargeting (21). We found that PCLN-1 mutants can be incorporated in TJ to some extent without binding to ZO-1 (Fig. 3) but could not record lysosomal mistargeting, because the mutants were widely distributed in the lateral membrane. The mutants unbound to ZO-1 did not increase both TER and divalent cation permeability. We suggest that ZO-1 is arranged by the dissociation of other complexes and concentrates PCLN-1 at the TJ. However, it is difficult to prove this hypothesis, because the stoichiometry of occludin and claudins in a single TJ fibril and their oligomerization into heteromeric and heterotypic assemblies are still unknown.

The reabsorption of magnesium and calcium in TAL occurs passively via the paracellular pathway under the apical-positive transepithelial potential difference (25, 26). Our present results indicate that calcium can be transported across monolayers of MDCK cells grown on permeable filters. PCLN-1 increased calcium transport from apical to basal compartments without affecting transport from basal to apical compartments. Furthermore, the apical-positive potential gradient enhanced calcium transport from apical to basal compartments. Interestingly, magnesium inhibited calcium transport in a dose-dependent manner, suggesting that PCLN-1 recognizes divalent positive charges. Negative residues on its extracellular loops are suggested to form paracellular channels selective for divalent cations (4). In the case of claudin-4, substitution of a negative charge for a positive one at position 65 in the first extracellular loop increases paracellular Na+ permeability (27). On the contrary, substitutions of positive for negative charges at three positions in the first extracellular loop of claudin-15 increase Cl- permeability. We hypothesize that the first extracellular loop of PCLN-1 looks toward the apical side and PCLN-1 can recognize divalent cations in the apical compartment. In addition, the elevation of divalent cations in the basal compartment may inhibit calcium transport via PCLN-1. The extracellular calcium/polyvalent cation-sensing protein is expressed in the basal membrane of epithelial cells in the proximal tubule, TAL, and distal tubule (28). It has been reported that the elevation of either basal calcium or magnesium decreases the reabsorption of calcium and magnesium in TAL (29). Further studies are required to clarify the residues involved in the recognition of divalent cations in PCLN-1.

In conclusion, the expression of the wild-type and TAV mutant of PCLN-1 increased TER and divalent cation permeability in accordance with the association between PCLN-1 and ZO-1, indicating that both Thr and Val residues at the C terminus of PCLN-1 are necessary for constructing the protein complex of functional TJ. Calcium transport from apical to basal compartments was regulated by the transepithelial potential gradient. In patients with FHHNC, mutations of PCLN-1 cause renal magnesium wasting, resulting in the development of nephrocalcinosis. The PCLN-1·ZO-1 complex at TJ may be essential for the reabsorption of divalent cations in renal epithelial cells.


    FOOTNOTES
 
* This work was supported in part by the grants from the Salt Science Research Foundation, number 0332, and the Takeda Science Foundation (to A. I.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact. Back

§ To whom correspondence should be addressed: Dept. of Environmental Biochemistry and Toxicology, University of Shizuoka School of Pharmaceutical Sciences, 52-1 Yada, Shizuoka 422-8526, Japan. Tel.: 81-54-264-5674; Fax: 81-54-264-5672; E-mail: ikari{at}u-shizuoka-ken.ac.jp.

1 The abbreviations used are: TAL, thick ascending limb; TJ, tight junction; PCLN-1, paracellin-1; SH, Src homology; GST, glutathione S-transferase; TER, transepithelial electrical resistance; MDCK, Madin-Darby canine kidney; FHHNC, familial hypomagnesemia with hypercalciuria and nephrocalcinosis. Back



    REFERENCES
 TOP
 ABSTRACT
 INTRODUCTION
 EXPERIMENTAL PROCEDURES
 RESULTS
 DISCUSSION
 REFERENCES
 

  1. Quamme, G. A., and de Rouffignac, C. (2000) Front. Biosci. 5, D694-D711[Medline] [Order article via Infotrieve]
  2. Gumbiner, B. M. (1993) J. Cell Biol. 123, 1631-1633[Free Full Text]
  3. Rodriguez-Boulan, E., and Nelson, W. J. (1989) Science 245, 718-725[Abstract/Free Full Text]
  4. Simon, D. B., Lu, Y., Choate, K. A., Velazquez, H., Al-Sabban, E., Praga, M., Casari, G., Bettinelli, A., Colussi, G., Rodriguez-Soriano, J., McCredie, D., Milford, D., Sanjad, S., and Lifton, R. P. (1999) Science 285, 103-106[Abstract/Free Full Text]
  5. Lim, I. A., Hall, D. D., and Hell, J. W. (2002) J. Biol. Chem. 277, 21697-21711[Abstract/Free Full Text]
  6. Lue, R. A., Marfatia, S. M., Branton, D., and Chishti, A. H. (1994) Proc. Natl. Acad. Sci. U. S. A. 91, 9818-9822[Abstract/Free Full Text]
  7. Olsen, O., and Bredt, D. S. (2003) J. Biol. Chem. 278, 6873-6878[Abstract/Free Full Text]
  8. Yamamoto, Y., Irie, K., Asada, M., Mino, A., Mandai, K., and Takai, Y. (2004) Oncogene 23, 3889-3897[CrossRef][Medline] [Order article via Infotrieve]
  9. Itoh, M., Furuse, M., Morita, K., Kubota, K., Saitou, M., and Tsukita, S. (1999) J. Cell Biol. 147, 1351-1363[Abstract/Free Full Text]
  10. Ikari, A., Nakano, M., Kawano, K., and Suketa, Y. (2002) J. Biol. Chem. 277, 33338-33343[Abstract/Free Full Text]
  11. Ikari, A., Nakajima, K., Kawano, K., and Suketa, Y. (2001) Biochem. Biophys. Res. Commun. 287, 671-674[CrossRef][Medline] [Order article via Infotrieve]
  12. Giuliano, A. R., and Wood, R. J. (1991) Am. J. Physiol. 260, G207-G212
  13. Kobayashi, J., Inai, T., and Shibata, Y. (2002) Histochem. Cell Biol. 117, 29-39[CrossRef][Medline] [Order article via Infotrieve]
  14. Morita, K., Furuse, M., Fujimoto, K., and Tsukita, S. (1999) Proc. Natl. Acad. Sci. U. S. A. 96, 511-516[Abstract/Free Full Text]
  15. Furuse, M., Itoh, M., Hirase, T., Nagafuchi, A., Yonemura, S., Tsukita, S., and Tsukita, S. (1994) J. Cell Biol. 127, 1617-1626[Abstract/Free Full Text]
  16. Yu, A. S., Enck, A. H., Lencer, W. I., and Schneeberger, E. E. (2003) J. Biol. Chem. 278, 17350-17359[Abstract/Free Full Text]
  17. Hasegawa, H., Fujita, H., Katoh, H., Aoki, J., Nakamura, K., Ichikawa, A., and Negishi, M. (1999) J. Biol. Chem. 274, 20982-20988[Abstract/Free Full Text]
  18. McCarthy, K. M., Francis, S. A., McCormack, J. M., Lai, J., Rogers, R. A., Skare, I. B., Lynch, R. D., and Schneeberger, E. E. (2000) J. Cell Sci. 113, 3387-3398[Abstract]
  19. Weber, S., Schneider, L., Peters, M., Misselwitz, J., Rönnefarth, G., Böswald, M., Bonzel, K. E., Seeman, T., Suláková, T., Kuwertz-Bröking, E., Gregoric, A., Palcoux, J. B., Tasic, V., Manz, F., Schärer, K., Seyberth, H. W., and Konrad, M. (2001) J. Am. Soc. Nephrol. 12, 1872-1881[Abstract/Free Full Text]
  20. Blanchard, A., Jeunemaitre, X., Coudol, P., Dechaux, M., Froissart, M., May, A., Demontis, R., Fournier, A., Paillard, M., and Houillier, P. (2001) Kidney Int. 59, 2206-2215[Medline] [Order article via Infotrieve]
  21. Müller, D., Kausalya, P. J., Claverie-Martin, F., Meij, I. C., Eggert, P., Garcia-Nieto, V., and Hunziker, W. (2003) Am. J. Hum. Genet. 73, 1293-1301[CrossRef][Medline] [Order article via Infotrieve]
  22. Van Itallie, C., Rahner, C., and Anderson, J. M. (2001) J. Clin. Investig. 107, 1319-1327[Medline] [Order article via Infotrieve]
  23. Amasheh, S., Meiri, N., Gitter, A. H., Schöneberg, T., Mankertz, J., Schulzke, J. D., and Fromm, M. (2002) J. Cell Sci. 115, 4969-4976[Abstract/Free Full Text]
  24. Balda, M. S., Whitney, J. A., Flores, C., Gonzalez, S., Cereijido, M., and Matter, K. (1996) J. Cell Biol. 134, 1031-1049[Abstract/Free Full Text]
  25. Quamme, G. A. (1997) Kidney Int. 52, 1180-1195[Medline] [Order article via Infotrieve]
  26. Monnens, L., Starremans, P., and Bindels, R. (2000) Nephrol. Dial. Transplant. 15, 568-571[Free Full Text]
  27. Colegio, O. R., Van Itallie, C. M., McCrea, H. J., Rahner, C., and Anderson, J. M. (2002) Am. J. Physiol. 283, C142-C147
  28. Riccardi, D., Hall, A. E., Chattopadhyay, N., Xu, J. Z., Brown, E. M., and Hebert, S. C. (1998) Am. J. Physiol. 274, F611-F622
  29. Quamme, G. A. (1989) Am. J. Physiol. 256, F197-F210

Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Am. J. Physiol. Renal Physiol.Home page
S. Angelow, R. Ahlstrom, and A. S. L. Yu
Biology of claudins
Am J Physiol Renal Physiol, October 1, 2008; 295(4): F867 - F876.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
J. Thumfart, S. Jung, S. Amasheh, S. Kramer, H. Peters, K. Sommer, J. Biber, H. Murer, I. Meij, U. Querfeld, et al.
Magnesium stimulates renal phosphate reabsorption
Am J Physiol Renal Physiol, October 1, 2008; 295(4): F1126 - F1133.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
R. T. Alexander, J. G. Hoenderop, and R. J. Bindels
Molecular Determinants of Magnesium Homeostasis: Insights from Human Disease
J. Am. Soc. Nephrol., August 1, 2008; 19(8): 1451 - 1458.
[Abstract] [Full Text] [PDF]


Home page
Mol. Biol. CellHome page
H. Fujita, K. Sugimoto, S. Inatomi, T. Maeda, M. Osanai, Y. Uchiyama, Y. Yamamoto, T. Wada, T. Kojima, H. Yokozaki, et al.
Tight Junction Proteins Claudin-2 and -12 Are Critical for Vitamin D-dependent Ca2+ Absorption between Enterocytes
Mol. Biol. Cell, May 1, 2008; 19(5): 1912 - 1921.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
S. Angelow, R. El-Husseini, S. A. Kanzawa, and A. S. L. Yu
Renal localization and function of the tight junction protein, claudin-19
Am J Physiol Renal Physiol, July 1, 2007; 293(1): F166 - F177.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
C.-T. Chang, C.-C. Hung, Y.-C. Tian, C.-W. Yang, and M.-S. Wu
Ciclosporin reduces paracellin-1 expression and magnesium transport in thick ascending limb cells
Nephrol. Dial. Transplant., April 1, 2007; 22(4): 1033 - 1040.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
N. Charoenphandhu, K. Tudpor, N. Pulsook, and N. Krishnamra
Chronic metabolic acidosis stimulated transcellular and solvent drag-induced calcium transport in the duodenum of female rats
Am J Physiol Gastrointest Liver Physiol, September 1, 2006; 291(3): G446 - G455.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
B. A. Appleton, Y. Zhang, P. Wu, J. P. Yin, W. Hunziker, N. J. Skelton, S. S. Sidhu, and C. Wiesmann
Comparative Structural Analysis of the Erbin PDZ Domain and the First PDZ Domain of ZO-1: INSIGHTS INTO DETERMINANTS OF PDZ DOMAIN SPECIFICITY
J. Biol. Chem., August 4, 2006; 281(31): 22312 - 22320.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y. Zhang, S. Yeh, B. A. Appleton, H. A. Held, P. J. Kausalya, D. C. Y. Phua, W. Lee Wong, L. A. Lasky, C. Wiesmann, W. Hunziker, et al.
Convergent and Divergent Ligand Specificity among PDZ Domains of the LAP and Zonula Occludens (ZO) Families
J. Biol. Chem., August 4, 2006; 281(31): 22299 - 22311.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
D. Muller, P. J. Kausalya, D. Bockenhauer, J. Thumfart, I. C. Meij, M. J. Dillon, W. v. Hoff, and W. Hunziker
Unusual Clinical Presentation and Possible Rescue of a Novel Claudin-16 Mutation
J. Clin. Endocrinol. Metab., August 1, 2006; 91(8): 3076 - 3079.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
A. Ikari, S. Matsumoto, H. Harada, K. Takagi, H. Hayashi, Y. Suzuki, M. Degawa, and M. Miwa
Phosphorylation of paracellin-1 at Ser217 by protein kinase A is essential for localization in tight junctions
J. Cell Sci., May 1, 2006; 119(9): 1781 - 1789.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
D. Muller, P. J. Kausalya, I. C. Meij, and W. Hunziker
Familial hypomagnesemia with hypercalciuria and nephrocalcinosis: blocking endocytosis restores surface expression of a novel Claudin-16 mutant that lacks the entire C-terminal cytosolic tail
Hum. Mol. Genet., April 1, 2006; 15(7): 1049 - 1058.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
W. M. T. Groenestege, J. G. Hoenderop, L. van den Heuvel, N. Knoers, and R. J. Bindels
The Epithelial Mg2+ Channel Transient Receptor Potential Melastatin 6 Is Regulated by Dietary Mg2+ Content and Estrogens
J. Am. Soc. Nephrol., April 1, 2006; 17(4): 1035 - 1043.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
D. F. Balkovetz
Claudins at the gate: determinants of renal epithelial tight junction paracellular permeability
Am J Physiol Renal Physiol, March 1, 2006; 290(3): F572 - F579.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
D. B. N. Lee, E. Huang, and H. J. Ward
Tight junction biology and kidney dysfunction
Am J Physiol Renal Physiol, January 1, 2006; 290(1): F20 - F34.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
279/52/54826    most recent
M406331200v2
M406331200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow